Categories
Seniors

Calico gathers top researchers to address aging and associated diseases

http://bits.blogs.nytimes.com/2013/09/18/google-and-former-genentech-chief-announce-new-biotech-company/

https://plus.google.com/+LarryPage/posts/Lh8SKC6sED1

Calico, announced in September by Larry Page, is on a mission to extend the human life span and will “help prevent many diseases and have a greater impact on public health than drugs that target individual diseases.”   Its CEO, Arthur Levinson, has made several high profile hires, expected to begin work in San Francisco soon.

Hal Barron will leave his post as the chief medical officer at Roche to oversee research and development. Dr. Robert Cohen, senior oncologist at Genentech has joined, along with Dr. Cynthia Kenyon, 55, a molecular biologist who discovered a genetic mutation that can double the lifespan of a tiny round worm, and David Botstein, 71, director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University.

ApplySci awaits, and will report on, Calico’s progress.  Stay posted.

Categories
Brain Sensors

Molecular sensor for early detection of Multiple Sclerosis

http://onlinelibrary.wiley.com/doi/10.1002/ana.24078/abstract

UCSF’s Gladstone Institute researchers have created a molecular sensor that can detect MS at its earliest stages — before the onset of physical signs. Professor Katerina Akassoglou’s study revealed in animal models that the heightened activity of a protein called thrombin in the brain could serve as an early indicator of MS. By developing a fluorescently labeled probe specifically designed to track thrombin, the team found that active thrombin could be detected at the earliest phases of MS, and that this active thrombin correlates with disease severity.

In laboratory experiments on mice modified to mimic the signs of MS, the team employed an Activatable Cell-Penetrating Peptide, a molecular probe that delivers fluorescent agents to a region of interest. For this study, they developed a thrombin-specific probe that could track thrombin activity in mice as the disease progressed. They then analyzed where, and at what stage of disease, thrombin activity was found.

“We detected heightened thrombin activity at specific disease ‘hot-spots,’ regions where neuronal damage developed over time,” said Gladstone scientist Dimitrios Davalos, “And when we compared these results to those of a separate, healthy control group of mice, we saw that thrombin activity in the control group was wholly absent.”

Categories
Cancer Sensors

Capsule endoscopy modification detects stomach cancer via “diagnostic pill”

http://www.inderscience.com/info/inarticle.php?artid=57925

Researchers at Chongqing University in China have developed an ingestible capsule capable of detecting chemical precursors of a gastric tumor. The findings might allow oncologists to catch the disease at a very early stage.  It is based on a modification of existing capsule endoscopy to detect occult bleeding  — tiny quantities of blood associated with the earliest stages of stomach cancer.

The diagnostic pill is encased in a non-toxic and acid-safe polycarbonate shell and carries its own power supply, transmitter, and a sensor with a detection limit of six micrograms per liter of fluid.

Categories
Monitoring

Illinois and NIH researchers develop ultrathin “diagnostic skin” for continuous monitoring

http://newswise.com/articles/ultrathin-diagnostic-skin-allows-continuous-patient-monitoring

Subtle variations in temperature can indicate harmful underlying conditions such as constriction or dilation of blood vessels or dehydration. Even changes in mental activity, such as increased concentration while solving a mathematical equation, are accompanied by measureable changes in body temperature.

University of Illinois researchers and the National Institute of Biomedical Imaging and Bioengineering have developed a sophisticated, continous temperature measuring ”electronic skin” that adheres non-invasively to human skin, conforms well to contours, and provides a detailed temperature map of any surface of the body.

The temperature sensor array is a variation of a technology developed by Professor John Rogers at the University of Illinois called “epidermal electronics,” consisting of ultrathin, flexible skin-like arrays, which resemble a tattoo of a micro-circuit board. The arrays developed with NIBIB contain sensors and heating elements. The technology offers the potential for a wide range of diagnostic and therapeutic capabilities with little patient discomfort.

Categories
Autism Brain

Micromovement study for diagnosing autism severity

http://news.medicine.iu.edu/releases/2013/12/jose-neuroscience.shtml

Indiana University professor Jorge V. José and Rutgers professor Elizabeth Torres are building on findings involving the random nature of movements of people with autism.  Earlier research looked at the speed maximum and randomness of movement during a computer exercise that involved tracking the motions of youths with autism when touching an image on the screen to indicate a decision.  In the new study, the researchers looked at the entire movement involved in raising and extending a hand to touch a computer screen. The device they use can record 240 frames per second, which allows them to measure speed changes in the millisecond range.

According to Professor Jose:  “Looking at the speed versus time curves of the motion in much more detail, we noticed that in general many smaller oscillations or fluctuations occur even when the hand is resting in the lap. We decided to carefully study that jitter. Our remarkable finding is that the fluctuations in this jitter are not just random fluctuations, but they do correspond to unique characteristics of the degree of autism each child has.”

The next step is to compare the output of the new methodology in individuals with autism of idiopathic origins with those with autism of known etiology. The new refinement may help advance research in autism spectrum disorder to develop treatments tailored to the individual’s needs and capabilities.

Categories
BCI Brain Stroke

Thought controlled device helps stroke patients move limbs

https://www.radiology.wisc.edu/research/currentProjects_details.php?id=368

http://www.sacbee.com/2013/12/01/5961969/novel-rehabilitation-device-improves.html

Professor Vivek Prabhakaran at the University of Wisconsin is developing a device that combines a brain-computer interface with electrical stimulation of damaged muscles to help stroke patients relearn how to move limbs.  Eight patients who had lost movement in one hand have been through six weeks of therapy with the device. They reported improvements in their ability to complete daily tasks.

Patients wear a cap of electrodes that picks up brain signals. Those signals are decoded by a computer. The computer sends tiny jolts of electricity through wires to sticky pads placed on the muscles of a patient’s paralyzed arm. The jolts act like nerve impulses, telling the muscles to move.  A video game prompts patients to try to hit a target by moving a ball with their affected arm. Patients practice with the game for two hours, every other day.

Researchers scanned the patients’ brains before, during and a month after they finished 15 sessions with the device.  The more patients practiced, the more they were able to train their brains.

Categories
BCI Brain

Emotion detection via expression reading algorithms

http://www.nytimes.com/2013/12/01/technology/when-algorithms-grow-accustomed-to-your-face.html

The emotion reading market, based on facial recognition aglorithms, is developing rapidly.

Companies in this field include Affectiva and Emotient. Affectiva used webcams over two and a half years to accumulate and classify about 1.5 billion emotional reactions from people as they watched streaming video.  These recordings served as a database to create the company’s face-reading software, which it will offer to mobile software developers starting in mid-January.

Categories
Assistive Technologies BCI Sensors Wearables

Tongue based magnetic field controls wheelchair

http://stm.sciencemag.org/content/5/213/213ra166

Maysam Ghovanloo of Georgia Tech and Anne Laumann of Northwestern have developed a tongue piercing based magnet to operate a wheelchair.

The device is a small magnetic barbell which creates a magnetic field in the mouth. When users flick their tongues, it alters that field. The change is picked up by four small sensors on a headset with twin extensions curving around the cheeks, and relayed wirelessly to a smartphone, computer or iPod. The software translates the signals and sends them to a powered wheelchair or computer.

The system was tested on 11 tetraplegia patients from rehabilitation centers in Chicago and Atlanta and 23 able volunteers who already wore tongue jewelry.

After 30 minutes of training, everyone was able to move a computer cursor, clicking on targets on a laptop screen, playing video games and dialing phone numbers. Accuracy and speed improved with practice, even though subjects used the system only one day a week. After six weeks the tetraplegics were, on average, three times faster with the tongue system than with sip-and-puff, which six of the 11 had been using. It was equally accurate.

Using only tongue movements, the volunteers also navigated a powered wheelchair through a 50-meter-long course with 13 turns, 24 obstacles and occasional alarms signaling “Stop! Emergency!” Here, too, on average the 11 tetraplegics drove the course three times faster with the tongue system than with sip-and-puff, and just as accurately.

Categories
mHealth Monitoring Sensors Wearables

Sony’s “SmartWig” can monitor and transmit health data

US Patent Office

Sony has submitted a patent application for a health monitoring “SmartWig.”  It can include a GPS and camera placed near the forehead. Users can receive vibrating feedback on specific parts of their head.  A laser pointer and remote can be controlled by the head’s movement. An ultrasound transducer could transmit or receive ultrasound waves to detect surrounding objects, warning users if there are obstacles behind or above their heads.  A circuit board in the hair can talk to a second device wirelessly — such as a phone or pair of smartglasses.

Categories
Brain

Glowing worm imaging system to study neural circuitry; can impact drug development

http://www.pnas.org/content/110/45/E4266

Worcester Polytechnic Institute and Rockefeller University researcher in have developed a system to image brain activity in multiple awake and unconstrained worms. The technology makes it possible to study the genetics and neural circuitry associated with animal behavior.  It can also be used as a high-throughput screening tool for drug development targeting autism, anxiety, depression, schizophrenia, and other brain disorders.

Numerous studies have been done by “worm labs” around the world exploring various neurological processes in C. elegans. These have typically been done using one worm at a time, with the animal’s body fixed in place on a slide. In his paper, Professor Dirk Albrecht’s team details how they imaged, recorded, and analyzed specific neurons in multiple animals as they wormed their way around a custom-designed microfluidic array, called an arena, where they were exposed to favorable or hostile sensory cues.

The team engineered a strain of worms with neurons near the head that would glow when they sensed food odors. In experiments involving up to 23 worms at a time, Albrecht’s team infused pulses of attractive or repulsive odors into the arena and watched how the worms reacted. In general, the worms moved towards the positive odors and away from the negative odors, but the behaviors did not always follow this pattern.

In addition to watching the head neurons light up as they picked up odor cues, the new system can trace signaling through “interneurons.” These are pathways that connect external sensors to the rest of the network (the “worm brain”) and send signals to muscle cells that adjust the worm’s movement based on the cues. Numerous brain disorders in people are believed to arise when neural networks malfunction. In some cases the malfunction is dramatic overreaction to a routine stimulus, while in others it is a lack of appropriate reactions to important cues. Since C. elegans and humans share many of the same genes, discovering genetic causes for differing neuronal responses in worms could be applicable to human physiology. Experimental compounds designed to modulate the action of nerve cells and neuronal networks could be tested first on worms using Albrecht’s new system. The compounds would be infused in the worm arena, along with other stimuli, and the reaction of the worms’ nervous systems could be imaged and analyzed.

Categories
Monitoring Seniors Sensors

NEC’s PaPeRo Petit robot uses third party apps to monitor seniors at home

http://jpn.nec.com/press/201311/20131111_01.html

NEC has introduced the PaPeRo Petit robot, which is about half the size of earlier PaPeRo senior companions, and a cloud computing system for services using the new robot.  PaPeRo Petit combines multiple sensors (cameras, ultrasonic range finders, temperature sensor, and microphones) to detect people and look in their direction even in complete darkness.  It can also link to online databases to better communicate with loved ones.  The robot can recognize faces and has between 80 to 90 percent success rate at speech recognition.

Categories
Brain

Signal enhances survival of new brain cells – can impact treatment of Alzheimers, Schizophrenia

http://www.nature.com/neuro/journal/vaop/ncurrent/full/nn.3572.html

Last year Johns Hopkins researchers reported that brain cells known as parvalbumin-expressing interneurons instruct nearby stem cells not to divide by releasing a chemical signal called GABA.

In a new study, Professors Hongiun Song and Guo-li Ming wanted to find out how GABA from surrounding neurons affects the newborn neurons that stem cells produce. Many of these newborn neurons naturally die soon after their “birth,” Song says; if they do survive, the new cells migrate to a permanent home in the brain and forge connections called synapses with other cells.

To learn whether GABA is a factor in the newborn neurons’ survival and behavior, the research team tagged newborn neurons from mouse brains with a fluorescent protein and then watched their response to GABA.

“We didn’t expect these immature neurons to form synapses, so we were surprised to see that they had built synapses from surrounding interneurons and that GABA was getting to them that way,” Song says. In the earlier study, the team had found that GABA was getting to the synapse-less stem cells by a less direct route, drifting across the spaces between cells.

The team engineered the interneurons to be either stimulated or suppressed by light. When stimulated, the cells would indeed activate nearby newborn neurons, the researchers found. They next tried the light-stimulation trick in live mice, and found that when the specialized interneurons were stimulated and gave off
more GABA, the mice’s newborn neurons survived in greater numbers than otherwise. This was in contrast to the response of the stem cells, which go dormant when they detect GABA.

“This appears to be a very efficient system for tuning the brain’s response to its environment,” says Song. “When you have a high level of brain activity, you need more newborn neurons, and when you don’t have high activity, you don’t need newborn neurons, but you need to prepare yourself by keeping the stem cells active. It’s all regulated by the same signal.”

Song notes that parvalbumin-expressing interneurons have been found by others to behave abnormally in neurodegenerative diseases such as Alzheimer’s and mental illnesses such as schizophrenia.